126 related articles for article (PubMed ID: 34326757)
1. Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma.
Ferreira Santos da Cruz N; Milhomens Filho JAP; Ferraro DMN; Polizelli MU; de Moraes Ambrogini NSB
Case Rep Ophthalmol; 2021; 12(2):578-584. PubMed ID: 34326757
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma.
Georgakopoulos CD; Plotas P; Angelakis A; Kagkelaris K; Tzouvara E; Makri OE
Ther Adv Ophthalmol; 2019; 11():2515841418820441. PubMed ID: 30671569
[TBL] [Abstract][Full Text] [Related]
3. Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema.
Besirli CG; Johnson MW
Retin Cases Brief Rep; 2013; 7(4):319-24. PubMed ID: 25383828
[TBL] [Abstract][Full Text] [Related]
4. An otherwise healthy young man presents with bilateral CRVO as the first sign of hyperviscosity syndrome in the setting of new multiple myeloma.
Golesic EA; Sheidow TG
Retin Cases Brief Rep; 2015; 9(1):38-40. PubMed ID: 25383860
[TBL] [Abstract][Full Text] [Related]
5. Immunogammopathy Maculopathy Secondary to Waldenström's Macroglobulinemia Complicated With Diabetic Retinopathy: A Case Report and Literature Review.
Ogata N; Ueda K; Aoki S
Cureus; 2023 Jul; 15(7):e41622. PubMed ID: 37565119
[TBL] [Abstract][Full Text] [Related]
6. Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only.
Blau-Most M; Gepstein R; Rubowitz A
Am J Ophthalmol Case Rep; 2018 Dec; 12():49-51. PubMed ID: 30182070
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.
Li J; Zhang R; Gu F; Liu ZL; Sun P
World J Clin Cases; 2020 Dec; 8(23):6071-6079. PubMed ID: 33344607
[TBL] [Abstract][Full Text] [Related]
8. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
Grannis CH; Dewan VN; Wang RC
Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
[TBL] [Abstract][Full Text] [Related]
9. Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma.
Dogan B; Erol MK; Toslak D; Coban DT; Bulut M; Cengiz A; Sari ES
Ther Clin Risk Manag; 2015; 11():683-9. PubMed ID: 25995641
[TBL] [Abstract][Full Text] [Related]
10. Hyperviscosity retinopathy as the initial presentation of aggressive multiple myeloma.
Kuo HH; Shen EP
Tzu Chi Med J; 2020; 32(4):401-403. PubMed ID: 33163389
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of plasmapheresis as treatment for bilateral hyperviscosity syndrome related retinopathy in multiple myeloma.
Merz T; Marchesoni I; Caminiti G; Romanelli F
Eur J Ophthalmol; 2022 Jul; 32(4):NP48-NP51. PubMed ID: 33601903
[TBL] [Abstract][Full Text] [Related]
12. Unusual maculopathy secondary to hypergammaglobulinemia in a patient with systemic lupus erythematosus.
Lin CJ; Chiu YM; Chen SN; Hwang JF; Hu PS
Retin Cases Brief Rep; 2012; 6(1):27-9. PubMed ID: 25390704
[TBL] [Abstract][Full Text] [Related]
13. Unusual immunogammopathy maculopathy.
Ho AC; Benson WE; Wong J
Ophthalmology; 2000 Jun; 107(6):1099-103. PubMed ID: 10857829
[TBL] [Abstract][Full Text] [Related]
14. Concomitant multiple myeloma spectrum diagnosis in a central retinal vein occlusion: a case report and review.
Borgman CJ
Clin Exp Optom; 2016 Jul; 99(4):309-12. PubMed ID: 27079282
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab in macular serous detachments associated with Waldenstrom's macroglobulinemia.
Kapoor KG; Wagner MS
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):95-7. PubMed ID: 25559519
[TBL] [Abstract][Full Text] [Related]
16. Bilateral central retinal vein occlusion associated with multiple myeloma.
Aggio FB; Cariello AJ; Almeida MS; Rodrigues CA; De Moraes NS; Colleoni GW; Farah ME
Ophthalmologica; 2004; 218(4):283-7. PubMed ID: 15258420
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Treatment Outcomes of Recurrent Central Retinal Vein Occlusions.
Chhablani J; Stewart M; Paulose R; Gallego-Pinazo R; Dolz-Marco R
Semin Ophthalmol; 2018; 33(2):191-197. PubMed ID: 27610480
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia.
Xu LT; Courtney RJ; Ehlers JP
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):262-5. PubMed ID: 25707055
[TBL] [Abstract][Full Text] [Related]
19. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
20. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
Pilon AF; Rhee PS; Messner LV
Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
